Skip to main content

Exagen Receives CAP Accreditation

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Molecular diagnostics laboratory Exagen Diagnostics today announced it has received accreditation from the College of American Pathologists.

As a result, Exagen becomes one of more than 17,000 CAP-accredited labs around the world. Based in Albuquerque, N.M., Exagen develops and markets genomic tests.

"As we continue to develop new genomic tests independently and through partnerships with pharmaceutical and diagnostics companies, having CAP accreditation validates our position as one of the world's most forward-looking laboratories," said Exagen Clinical Laboratory Director John Hozier, said in a statement.

CAP accreditation is based on an on-site inspection of the laboratory's records and quality-control procedures for the preceding two years, laboratory staff qualifications, and laboratory equipment, among other things.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.